Abstract
© 2013 by Canadian Psychiatric Association, Canadian Journal of Psychiatry / Revue Canadienene de Psychiatrie
Highlights
Why Are Canadians Complacent About Long-Acting Injectable Antipsychotic Therapies? Come on, Canada, You Can Do Better!
As a psychiatrist specializing in serious mental illness, I am appalled by the shortcomings of the US mental health care system
When I received Dr Ashok Malla’s generous invitation to be the guest editor for this special issue on the state of long-acting treatments for schizophrenia in Canada, I accepted with enthusiasm
Summary
Why Are Canadians Complacent About Long-Acting Injectable Antipsychotic Therapies? Come on, Canada, You Can Do Better!. I assumed that the situation regarding the use of LAI therapies would have to be better in Canada than it is in the United States because the LAI lends itself to integrated mental health services.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
